Tag: Phase III
BrainStorm Cell Therapeutics Passes Safety Milestone In Phase 3 Trial Of NurOwn® Therapy for...
BrainStorm Cell Therapeutics Inc., founded in 2004, based in New York City, is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases.
The Company...